Apimeds Pharmaceuticals US, Inc.
Recent Filings
All 106 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 26, 2026 |
| 8-K | CURRENT REPORT | Mar 25, 2026 |
| SCHEDULE 13D/A | — | Mar 20, 2026 |
| 8-K | CURRENT REPORT | Mar 16, 2026 |
| DEFM14C | INFORMATION STATEMENT | Feb 27, 2026 |
| 425 | AMENDMENT NO. 2 TO FORM 8-K | Feb 17, 2026 |
| 8-K/A | AMENDMENT NO. 2 TO FORM 8-K | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 11, 2026 |
| SCHEDULE 13D/A | — | Jan 26, 2026 |
| PREM14C | INFORMATION STATEMENT | Jan 16, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kim Christopher | Chairman and CMO | Award / Grant | 250,000 | 277,500 | May 16, 2025 |
| Emerson Erik C. | Chief Executive Officer | Award / Grant | 750,000 | 750,000 | May 16, 2025 |
| Kim Christopher | Chairman and CMO | Purchase | 19,770 @ $1.82 | 19,770 | May 14, 2025 |
| Koo Jakap | — | Purchase | 28,500 @ $1.99 | 643,885 | May 12, 2025 |
| Inscobee Inc. | — | Purchase | 500,000 @ $4.00 | 1,984,616 | May 12, 2025 |